NO20043569D0 - Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyre - Google Patents
Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyreInfo
- Publication number
- NO20043569D0 NO20043569D0 NO20043569A NO20043569A NO20043569D0 NO 20043569 D0 NO20043569 D0 NO 20043569D0 NO 20043569 A NO20043569 A NO 20043569A NO 20043569 A NO20043569 A NO 20043569A NO 20043569 D0 NO20043569 D0 NO 20043569D0
- Authority
- NO
- Norway
- Prior art keywords
- metabolites
- sulfonyl
- phenoxy
- pyridine
- tert
- Prior art date
Links
- 125000003352 4-tert-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title 1
- 239000002207 metabolite Substances 0.000 title 1
- -1 pyridine-3-sulfonyl Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35374802P | 2002-01-31 | 2002-01-31 | |
| PCT/IB2003/000121 WO2003064391A1 (en) | 2002-01-31 | 2003-01-20 | Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20043569D0 true NO20043569D0 (no) | 2004-08-26 |
| NO20043569L NO20043569L (no) | 2004-08-26 |
Family
ID=27663249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043569A NO20043569L (no) | 2002-01-31 | 2004-08-26 | Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyre |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6852863B2 (es) |
| EP (1) | EP1470109A1 (es) |
| JP (1) | JP2005521668A (es) |
| KR (1) | KR20040077884A (es) |
| CN (1) | CN1625549A (es) |
| AP (1) | AP2004003094A0 (es) |
| AR (1) | AR038332A1 (es) |
| BR (1) | BR0307339A (es) |
| CA (1) | CA2473984A1 (es) |
| EA (1) | EA200400724A1 (es) |
| EC (1) | ECSP045215A (es) |
| GB (1) | GB2400100B (es) |
| HN (1) | HN2003000051A (es) |
| HR (1) | HRP20040683A2 (es) |
| HU (1) | HUP0500012A2 (es) |
| IL (1) | IL162167A0 (es) |
| IS (1) | IS7281A (es) |
| MA (1) | MA27169A1 (es) |
| MX (1) | MXPA04004960A (es) |
| NO (1) | NO20043569L (es) |
| OA (1) | OA12760A (es) |
| PA (1) | PA8564601A1 (es) |
| PE (1) | PE20030978A1 (es) |
| PL (1) | PL371982A1 (es) |
| TN (1) | TNSN04138A1 (es) |
| TW (1) | TW200302080A (es) |
| UY (1) | UY27632A1 (es) |
| WO (1) | WO2003064391A1 (es) |
| ZA (1) | ZA200404067B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| TWI332937B (en) * | 2005-04-20 | 2010-11-11 | Lg Chemical Ltd | Additive for non-aqueous electrolyte and secondary battery using the same |
| EA200970067A1 (ru) * | 2006-07-28 | 2009-08-28 | Пфайзер Продактс Инк. | Агонисты ep2 |
| CA2679882C (en) | 2007-03-08 | 2015-12-29 | The Board Of Trustees Of The Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
| EP2002834A1 (de) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryl/Hetarylamide als Modulatoren des EP2-Rezeptors |
| DK2264009T3 (en) * | 2008-03-12 | 2019-04-15 | Ube Industries | PYRIDYLAMINE ACEDIC ACID COMPOUND |
| EP2149554A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma Aktiengesellschaft | Indolylamide als Modulatoren des EP2-Rezeptors |
| EP2149552A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors |
| EP2149551A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | N-(Indol-3-ylalkyl)-(hetero)arylamidderivate als Modulatoren des EP2-Rezeptors |
| CN102209541B (zh) | 2008-09-08 | 2016-05-18 | 小利兰·斯坦福大学托管委员会 | 醛脱氢酶活性调节剂和其使用方法 |
| WO2010062308A1 (en) | 2008-10-28 | 2010-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase and methods of use thereof |
| CA2757291C (en) | 2009-03-30 | 2017-05-23 | Ube Industries, Ltd. | Medical composition for treatment or prophylaxis of glaucoma |
| DE102009049662A1 (de) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten |
| US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
| TW201326154A (zh) | 2011-11-28 | 2013-07-01 | 拜耳知識產權公司 | 作為ｅｐ２受體拮抗劑之新穎２ｈ－吲唑 |
| JP6410790B2 (ja) | 2013-03-14 | 2018-10-24 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ミトコンドリアアルデヒドデヒドロゲナーゼ−２調節因子およびその使用方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (uk) | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
-
2003
- 2003-01-20 WO PCT/IB2003/000121 patent/WO2003064391A1/en active Application Filing
- 2003-01-20 PL PL03371982A patent/PL371982A1/xx not_active Application Discontinuation
- 2003-01-20 IL IL16216703A patent/IL162167A0/xx unknown
- 2003-01-20 EP EP03700072A patent/EP1470109A1/en not_active Withdrawn
- 2003-01-20 HU HU0500012A patent/HUP0500012A2/hu unknown
- 2003-01-20 AP APAP/P/2004/003094A patent/AP2004003094A0/en unknown
- 2003-01-20 MX MXPA04004960A patent/MXPA04004960A/es unknown
- 2003-01-20 CN CNA038029952A patent/CN1625549A/zh active Pending
- 2003-01-20 JP JP2003564014A patent/JP2005521668A/ja active Pending
- 2003-01-20 CA CA002473984A patent/CA2473984A1/en not_active Abandoned
- 2003-01-20 BR BR0307339-4A patent/BR0307339A/pt not_active IP Right Cessation
- 2003-01-20 GB GB0413967A patent/GB2400100B/en not_active Expired - Fee Related
- 2003-01-20 KR KR10-2004-7011618A patent/KR20040077884A/ko not_active Application Discontinuation
- 2003-01-20 OA OA1200400198A patent/OA12760A/en unknown
- 2003-01-20 EA EA200400724A patent/EA200400724A1/ru unknown
- 2003-01-24 TW TW092101619A patent/TW200302080A/zh unknown
- 2003-01-28 HN HN2003000051A patent/HN2003000051A/es unknown
- 2003-01-28 PE PE2003000086A patent/PE20030978A1/es not_active Application Discontinuation
- 2003-01-29 US US10/353,671 patent/US6852863B2/en not_active Expired - Fee Related
- 2003-01-29 AR ARP030100254A patent/AR038332A1/es unknown
- 2003-01-30 PA PA20038564601A patent/PA8564601A1/es unknown
- 2003-01-30 UY UY27632A patent/UY27632A1/es not_active Application Discontinuation
-
2004
- 2004-05-21 IS IS7281A patent/IS7281A/is unknown
- 2004-05-25 ZA ZA200404067A patent/ZA200404067B/en unknown
- 2004-07-21 MA MA27796A patent/MA27169A1/fr unknown
- 2004-07-23 HR HR20040683A patent/HRP20040683A2/hr not_active Application Discontinuation
- 2004-07-27 TN TNP2004000138A patent/TNSN04138A1/fr unknown
- 2004-07-30 EC EC2004005215A patent/ECSP045215A/es unknown
- 2004-08-26 NO NO20043569A patent/NO20043569L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1470109A1 (en) | 2004-10-27 |
| KR20040077884A (ko) | 2004-09-07 |
| WO2003064391A1 (en) | 2003-08-07 |
| PE20030978A1 (es) | 2003-11-19 |
| MXPA04004960A (es) | 2005-04-08 |
| EA200400724A1 (ru) | 2004-12-30 |
| TW200302080A (en) | 2003-08-01 |
| US20030216445A1 (en) | 2003-11-20 |
| TNSN04138A1 (fr) | 2007-03-12 |
| GB0413967D0 (en) | 2004-07-28 |
| AP2004003094A0 (en) | 2004-09-30 |
| PA8564601A1 (es) | 2003-09-05 |
| JP2005521668A (ja) | 2005-07-21 |
| IL162167A0 (en) | 2005-11-20 |
| GB2400100A (en) | 2004-10-06 |
| IS7281A (is) | 2004-05-21 |
| AR038332A1 (es) | 2005-01-12 |
| MA27169A1 (fr) | 2005-01-03 |
| HUP0500012A2 (hu) | 2005-04-28 |
| GB2400100B (en) | 2006-04-12 |
| PL371982A1 (en) | 2005-07-11 |
| BR0307339A (pt) | 2004-12-07 |
| ECSP045215A (es) | 2004-09-28 |
| HN2003000051A (es) | 2003-09-24 |
| OA12760A (en) | 2006-07-04 |
| US6852863B2 (en) | 2005-02-08 |
| NO20043569L (no) | 2004-08-26 |
| CN1625549A (zh) | 2005-06-08 |
| UY27632A1 (es) | 2003-08-29 |
| HRP20040683A2 (en) | 2004-10-31 |
| CA2473984A1 (en) | 2003-08-07 |
| ZA200404067B (en) | 2005-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043569D0 (no) | Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyre | |
| NO20050118D0 (no) | Substituerte fenylsulfonamidinhibitorer av beta-amyolid produksjon | |
| CY2016042I2 (el) | Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων | |
| CY2015015I1 (el) | Παραγωγη τιακουμυκινης | |
| DE60336251D1 (de) | Identifikation von aufzeichnungsmedien | |
| NO20032645L (no) | Heterocykliske sulfonamidinhibitorer av <beta>- amyloidproduksjonen | |
| NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
| DK1488790T3 (da) | Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat | |
| HRP20050361A2 (en) | Synthesis of thiophenecarboxylic acid esters for the production of ramelic acid salts | |
| NO20050563L (no) | N-aryl-piperidinsubstituerte bifenylkarboksamider som inhibitorer av apolipoprotein B-sekresjon | |
| NO20043102L (no) | Fjerning av sure gasser | |
| NO20054408D0 (no) | 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose | |
| EA200500201A1 (ru) | Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина | |
| HRP20080027T3 (en) | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide | |
| IS8231A (is) | Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða | |
| JP2007506758A5 (ja) | ４−（１−ベンゾフラン−３−イル−メチリデンアミノオキシ−プロポキシ）−安息香酸誘導体および線溶系の障害、血栓症の治療用のｐａｉ−１阻害剤としての関連化合物 | |
| IS2136B (is) | Aðferð til nýmyndunar í iðnaði á metýldíester 5-amínó-3-karboxýmetýl-4-sýanó-2-þíófenkarboxýlsýru | |
| EE200300343A (et) | Pantoteenhappe võimendatud produktsiooni meetod | |
| DE60216641D1 (de) | Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure | |
| IS8232A (is) | Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða | |
| EA200500204A1 (ru) | Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина | |
| CY2011018I1 (el) | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος | |
| NO20023921D0 (no) | Derivater av thiazepinylhydroksamisk syre som inhibitorer av matriks metalloproteinase | |
| DE60323748D1 (de) | 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung | |
| NO20021965D0 (no) | Hydroksamsyrederivat som inhibitor av dannelsen av opplöselig, human CD23 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |